Alvesco and Pradaxa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alvesco (ciclesonide) and Pradaxa (dabigatran etexilate mesylate). Common drug interactions include dyspnoea among females and body temperature decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Alvesco and Pradaxa. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Alvesco?

Alvesco has active ingredients of ciclesonide. It is often used in asthma. eHealthMe is studying from 13,134 Alvesco users. Check the latest studies of Alvesco.

What is Pradaxa?

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.

On Jul, 11, 2026

26 people who take Alvesco and Pradaxa together, and have interactions are studied.

What are the common drug interactions of Alvesco and Pradaxa, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Pneumonia
Device occlusion
Dysphagia (a condition in which swallowing is difficult or painful)
Heart valve stenosis (abnormal narrowing of the aortic valve in the heart)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Throat irritation
Urticaria (rash of round, red welts on the skin that itch intensely)
Anaemia (lack of blood)
Contusion (a type of hematoma of tissue in which capillaries)

male:

Body temperature decreased
Cerebral infarction (less blood supply to brain resulting tissue damage)
Dyspnoea (difficult or laboured respiration)
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Disturbance in attention
Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
Nervousness
Pyrexia (fever)
Cough
Drug ineffective

What are the common drug interactions of Alvesco and Pradaxa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anaemia (lack of blood)
Chest discomfort
Cholecystitis (infection of gallbladder)
Drug effect decreased
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Haemorrhage (bleeding)
Mouth haemorrhage (bleeding from mouth)
Pancreatitis (inflammation of pancreas)

60+:

Dyspnoea (difficult or laboured respiration)
Pneumonia
Forced expiratory volume decreased (decreased lung expired air volume)
Gait disturbance
Respiratory tract infection
Lower respiratory tract infection
Body temperature decreased
Cerebral infarction (less blood supply to brain resulting tissue damage)
Cough
Heart rate irregular

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 30.77%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 15.38%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 15.38%
Insomnia (sleeplessness): 3 people, 11.54%
Hypersensitivity: 3 people, 11.54%
High Blood Cholesterol: 3 people, 11.54%
Heart Rate Irregular: 3 people, 11.54%
Gastritis (inflammation of stomach): 2 people, 7.69%
Bone Disorder: 2 people, 7.69%
Cough: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Alvesco and Pradaxa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously